Amgen Inc header image

Amgen Inc

AMGN

Equity

ISIN null / Valor 907582

NASDAQ (2026-05-06)
USD 329.72+1.77%

Amgen Inc
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

s a leading biotechnology company that focuses on addressing high unmet medical needs by developing innovative medicines to improve health outcomes and enhance the lives of patients worldwide. With a strong emphasis on science and innovation, Amgen leverages its expertise in understanding the biological mechanisms of disease to drive its discovery research efforts and build a deep pipeline of potential new medicines with breakthrough potential. Through its subsidiary deCODE Genetics, Amgen utilizes human genetics to identify and validate disease targets, further enhancing its research capabilities. As a global leader in biologics manufacturing, Amgen ensures the safe and reliable production of biologic medicines that are crucial for the treatment of millions of seriously ill patients. With a commitment to quality control and a reliable supply of medicines, Amgen's mission is to transform new ideas and discoveries into life-changing therapies for patients with serious illnesses.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.7%1Y
39.3%3Y
32.2%5Y

Performance

29.0%1Y
25.7%3Y
23.9%5Y

Volatility

Market cap

177882 M

Market cap (USD)

Daily traded volume (Shares)

3,321,412

Daily traded volume (Shares)

1 day high/low

261.55 / 258.74

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Zoe Holloway
United Kingdom, 07 Feb 2026
star star star star star
Steady upwards trend
Kendra Ho
United Kingdom, 06 Feb 2026
star star star star star
Overall good performance

EQUITIES OF THE SAME SECTOR

Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.49%GBP 29.19
Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%SEK 99.95
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 16.75
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 301.11
BeiGene Ltd
BeiGene Ltd BeiGene Ltd Valor: 30165310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%USD 297.49
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.59%EUR 2.70
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.84%USD 168.71
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.35%USD 121.32
CVS Group PLC
CVS Group PLC CVS Group PLC Valor: 3457960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.65%GBP 11.39
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.48%USD 50.44